查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1538166

永生化细胞株市场报告：2030 年趋势、预测与竞争分析

Immortalized Cell Line Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

永生化细胞株的趋势与预测

预计2024年至2030年全球永生化细胞株市场将以6.8%的复合年增长率成长。该市场的主要驱动力是需要器官移植的人数不断增加、癌症患者数量不断增加，以及该系列产品在药物发现、诊断测试、再生医学和生物技术研究等各种应用中的广泛使用。全球永生化细胞株市场的未来看起来充满希望，製药/生物製药、CRO 和实验室市场充满机会。

分段永生化细胞株

研究包括按产品类型、应用和地区对全球永生化细胞株的预测。

永生化细胞株市场洞察

Lucintel 预测干细胞疗法将在预测期内达到最高成长。

在该市场中，药品和生物製药在预测期内仍将是最大的细分市场。

由于癌症盛行率不断上升，并且是生物技术和製药行业的繁荣地区，北美在整个预测期内仍将是最大的地区。

常问问题

Q1.市场成长预测是多少：

A1. 2024年至2030年，全球永生化细胞株市场预计将以6.8%的复合年增长率成长。

Q2. 影响市场成长的关键驱动因素是：

A2. 该市场的主要驱动力是需要器官移植的人数不断增加、癌症患者数量不断增加，以及该系列产品在药物发现、诊断测试、再生医学和生物技术研究等各种应用中的广泛使用。 。

Q3.市场的主要细分市场是：

A3.永生化细胞株市场在製药/生物製药、CRO和实验室市场的前景广阔。

Q4.市场的主要企业是：

A4.主要永生化细胞株公司如下：

  • Thermo Fisher Scientific
  • ATCC
  • Valneva
  • Sartorius
  • Lonza Group
  • Merck
  • Selexis
  • WuXi App
  • European Collection of Authenticated Cell Cultures
  • Corning Incorporated

Q5.未来最大的细分市场是什么？

A5.Lucintel 预测干细胞疗法将在预测期内达到最高成长。

Q6.未来五年预计哪些地区的市场成长最大？

A6. 由于癌症盛行率上升以及生物技术和製药行业强劲，北美在预测期内仍然是最大的地区。

Q7. 可以客製化报告吗？

A7。

目录

第一章执行摘要

第二章全球永生化细胞株市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球永生化细胞株市场趋势（2018-2023）与预测（2024-2030）
  • 按产品类型分類的永生化细胞株的全球市场
    • 干细胞疗法
    • 细胞移植
    • 药物运输
    • 其他的
  • 按应用分類的永生化细胞株的全球市场
    • 药品/生物製药
    • CRO
    • 研究所
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 按地区分類的全球永生细胞株市场
  • 北美永生化细胞株市场
  • 欧洲永生化细胞株市场
  • 亚太永生细胞株市场
  • 其他地区永生化细胞株市场

第五章 竞争分析

  • 产品系列分析
  • 业务整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
  • 全球永生化细胞株市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球永生化细胞株市场产能
    • 全球永生化细胞株市场的合併、收购与合资
    • 认证和许可

第七章主要企业概况

  • Thermo Fisher Scientific
  • ATCC
  • Valneva
  • Sartorius
  • Lonza Group
  • Merck
  • Selexis
  • WuXi App
  • European Collection of Authenticated Cell Cultures
  • Corning Incorporated
简介目录

Immortalized Cell Line Trends and Forecast

The future of the global immortalized cell line market looks promising with opportunities in the pharmaceutical and biopharmaceutical, contract research organization, and research laboratory markets. The global immortalized cell line market is expected to grow with a CAGR of 6.8% from 2024 to 2030. The major drivers for this market are increasing number of individuals require organ transplantation, growing number of cancer patients, and expanding usage of this line in various application, such as drug discovery, diagnostic testing, regenerative medicine, and biotechnology research.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Immortalized Cell Line by Segment

The study includes a forecast for the global immortalized cell line by product type, application, and region.

Immortalized Cell Line Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Stem Cell Therapy
  • Cell Transplantation
  • Drug Transport
  • Others

Immortalized Cell Line Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical and Biopharmaceutical
  • Contract Research Organizations
  • Research Laboratories
  • Others

Immortalized Cell Line Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Immortalized Cell Line Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies immortalized cell line companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the immortalized cell line companies profiled in this report include-

  • Thermo Fisher Scientific
  • ATCC
  • Valneva
  • Sartorius
  • Lonza Group
  • Merck
  • Selexis
  • WuXi App
  • European Collection of Authenticated Cell Cultures
  • Corning Incorporated

Immortalized Cell Line Market Insights

Lucintel forecasts that stem cell therapy is expected to witness the highest growth over the forecast period.

Within this market, pharmaceutical and biopharmaceutical will remain the largest segment over the forecast period.

North America will remain the largest region over the forecast period due to rise in the prevalence of cancer as well as existence of a thriving biotechnology and pharmaceutical industry in the region.

Features of the Global Immortalized Cell Line Market

Market Size Estimates: Immortalized cell line market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Immortalized cell line market size by product type, application, and region in terms of value ($B).

Regional Analysis: Immortalized cell line market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, and regions for the immortalized cell line market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the immortalized cell line market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for immortalized cell line market?

Answer: The global immortalized cell line market is expected to grow with a CAGR of 6.8% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the immortalized cell line market?

Answer: The major drivers for this market are increasing number of individuals require organ transplantation, growing number of cancer patients, and expanding usage of this line in various application, such as drug discovery, diagnostic testing, regenerative medicine, and biotechnology research.

Q3. What are the major segments for immortalized cell line market?

Answer: The future of the immortalized cell line market looks promising with opportunities in the pharmaceutical and biopharmaceutical, contract research organization, and research laboratory markets.

Q4. Who are the key immortalized cell line market companies?

Answer: Some of the key immortalized cell line companies are as follows:

  • Thermo Fisher Scientific
  • ATCC
  • Valneva
  • Sartorius
  • Lonza Group
  • Merck
  • Selexis
  • WuXi App
  • European Collection of Authenticated Cell Cultures
  • Corning Incorporated

Q5. Which immortalized cell line market segment will be the largest in future?

Answer: Lucintel forecasts that stem cell therapy is expected to witness the highest growth over the forecast period.

Q6. In immortalized cell line market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rise in the prevalence of cancer as well as existence of a thriving biotechnology and pharmaceutical industry in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the immortalized cell line market by product type (stem cell therapy, cell transplantation, drug transport, and others), application (pharmaceutical and biopharmaceutical, contract research organizations, research laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Immortalized Cell Line Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Immortalized Cell Line Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Immortalized Cell Line Market by Product Type
    • 3.3.1: Stem Cell Therapy
    • 3.3.2: Cell Transplantation
    • 3.3.3: Drug Transport
    • 3.3.4: Others
  • 3.4: Global Immortalized Cell Line Market by Application
    • 3.4.1: Pharmaceutical and Biopharmaceutical
    • 3.4.2: Contract Research Organizations
    • 3.4.3: Research Laboratories
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Immortalized Cell Line Market by Region
  • 4.2: North American Immortalized Cell Line Market
    • 4.2.1: North American Immortalized Cell Line Market by Product Type: Stem Cell Therapy, Cell Transplantation, Drug Transport, and Others
    • 4.2.2: North American Immortalized Cell Line Market by Application: Pharmaceutical and Biopharmaceutical, Contract Research Organizations, Research Laboratories, and Others
  • 4.3: European Immortalized Cell Line Market
    • 4.3.1: European Immortalized Cell Line Market by Product Type: Stem Cell Therapy, Cell Transplantation, Drug Transport, and Others
    • 4.3.2: European Immortalized Cell Line Market by Application: Pharmaceutical and Biopharmaceutical, Contract Research Organizations, Research Laboratories, and Others
  • 4.4: APAC Immortalized Cell Line Market
    • 4.4.1: APAC Immortalized Cell Line Market by Product Type: Stem Cell Therapy, Cell Transplantation, Drug Transport, and Others
    • 4.4.2: APAC Immortalized Cell Line Market by Application: Pharmaceutical and Biopharmaceutical, Contract Research Organizations, Research Laboratories, and Others
  • 4.5: ROW Immortalized Cell Line Market
    • 4.5.1: ROW Immortalized Cell Line Market by Product Type: Stem Cell Therapy, Cell Transplantation, Drug Transport, and Others
    • 4.5.2: ROW Immortalized Cell Line Market by Application: Pharmaceutical and Biopharmaceutical, Contract Research Organizations, Research Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Immortalized Cell Line Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Immortalized Cell Line Market by Application
    • 6.1.3: Growth Opportunities for the Global Immortalized Cell Line Market by Region
  • 6.2: Emerging Trends in the Global Immortalized Cell Line Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Immortalized Cell Line Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Immortalized Cell Line Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: ATCC
  • 7.3: Valneva
  • 7.4: Sartorius
  • 7.5: Lonza Group
  • 7.6: Merck
  • 7.7: Selexis
  • 7.8: WuXi App
  • 7.9: European Collection of Authenticated Cell Cultures
  • 7.10: Corning Incorporated